Jaykay Enterprises Q2 FY27 Total Income Surges 69% YoY to ₹116 Crore
Jaykay Enterprises reported Q2 FY27 consolidated income of ₹116.16 crore, a 69% YoY jump. Profit After Tax was ₹8.66 crore. For H1 FY27, income rose 32% YoY to ₹192.95 crore with PAT of ₹13.18 crore. The company secured defence orders worth ₹60.01 crore and received CDSCO approval for medical implants.
The substantial YoY revenue growth, significant defence orders, and progress in key business segments like medical implants indicate a strong positive impact on the company's financial performance and future prospects.
The company reported significant year-on-year growth in total income and profit for both the quarter and half-year. Major defence orders and regulatory approvals for medical implants contribute to a positive outlook.
Jaykay Enterprises Ltd. announced its consolidated financial results for the quarter and half-year ended September 30, 2026. The company reported a total income of ₹116.16 crore for the second quarter of FY2026-27, marking a significant 69% year-on-year growth from ₹68.79 crore in Q2 FY2025-26. Profit After Tax for the quarter stood at ₹8.66 crore.
For the half-year ended September 30, 2026, total income increased by 32% year-on-year to ₹192.95 crore from ₹146.21 crore in the same period last year, with a Profit After Tax of ₹13.18 crore.
Key business highlights for the quarter include the Defence & Aerospace segment receiving AS9100D Accreditation for its JKE Precision Manufacturing Division and securing major defence orders worth ₹60.01 crore (inclusive of GST) from BrahMos Aerospace for its subsidiary, Allen Reinforced Plastics Ltd. The Devanahalli project in Bengaluru is on track for completion by Q4 FY26-27/Q1 FY27-28.
The Digital & Advanced Systems segment received regulatory approvals for its Medical Implants from CDSCO, with USFDA approval pending. The segment is also developing new products through Additive Manufacturing for Defence, Aerospace & SpaceTech sectors.
In the Digital Services Segment (JK Tech), AI Orchestration Platforms Jiva, Ontologos, and Orbiee signed Statements of Work (SOWs) with multiple customers, and pipeline for new customers is robust. The Board provided for delayed receivables due to business disruptions in the Middle East and other geopolitical developments as a matter of abundant caution.
Mr. Abhishek Singhania, Chairman and Managing Director, expressed optimism about the robust growth in Defence & Aerospace and Digital Manufacturing businesses, highlighting increasing customer acceptance for Additive Manufacturing for Defence & Medical Implants and continued investment in latest technologies across all business segments.
What to do with a filing like this
Jaykay Enterprises Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jaykay Enterprises Limited. Read the original for the full detail.